🇺🇸 FDA
Patent

US 10111926

Selectively targeted antimicrobial peptides and the use thereof

granted A61KA61K38/00A61K38/10

Quick answer

US patent 10111926 (Selectively targeted antimicrobial peptides and the use thereof) held by The Regents of the University of California expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/00, A61K38/10, A61K38/1709, A61K47/65